Lv12
40 积分 2024-10-09 加入
Efficacy and Safety of Radiation Segmentectomy with 90Y Resin Microspheres for Hepatocellular Carcinoma
1天前
已完结
Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multi-center prospective cohort study
1天前
已完结
Determination of tumour dose response threshold and implication on survival in patients with HCC treated with Y90 radiation segmentectomy: a simple semi-quantitative analysis
1天前
已完结
Complete tumor response after concomitant treatment with lenvatinib and radioembolization with Ytrio-90 of advanced stage hepatocarcinoma
4天前
已完结
Combining systemic and local therapies for hepatocellular carcinoma
4天前
已完结
Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials
6天前
已完结
Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Response
15天前
已完结
Baicalein tethers CD274/PD-L1 for autophagic degradation to boost antitumor immunity
16天前
已完结
The progress in dosimetric evaluation methods for 90Y microspheres radioembolization
1个月前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
